Key TakeawaysPrescription Digital Therapeutics (PDTs) are FDA-cleared, supported by clinical trials, and require healthcare provider prescriptions.PDTs offer scalable, nonpharmacologic treatment options, benefiting underserved populations and providing real-time adherence tracking.Challenges include reimbursement inequity, digital literacy issues, privacy concerns, and access inequities, particularly in underserved populations.PDTs demonstrate significant improvements in patient outcomes, such as ADHD symptom reduction […]

Author